A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

Tauopathies are neurodegenerative diseases characterised by the build-up in the brain of tau protein ‘aggregates’ within nerve cells. These include forms of dementia, Pick's disease and ...

are neurobiological lesions that are found in brain cells of patients with Alzheimer's disease (AD). They consist of aggregates of abnormally phosphorylated tau proteins that are altered in ...

Furthermore, NFTs may also contribute to the disease progression by effectively sequestering more tau and other proteins, and thereby reinforcing and amplifying the loss of normal tau function.

Tau is a protein that builds up and moves between nerve cells in the brains of people living with Alzheimer’s disease, causing damage. Professor Mudher is using clever genetic manipulation in fruit ...

Researchers from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) have found that tau protein and beta-amyloid – two pathological hallmarks of Alzheimer’s disease – ...

The research focused on tau, a protein that, when it accumulates abnormally in the brain, can lead to devastating ...

this protein has been found to contribute to some neurodegenerative diseases, broadly defined as tauopathies. Specifically, past research linked the levels of tau in the brains of patients ...

A characteristic feature of AD is the presence of neurofibrillary tangles, primarily composed of hyperphosphorylated tau protein ... including Pick's disease, progressive supranuclear palsy ...

The Swiss pharma group is paying $120 million upfront for exclusive global rights to UCB0107, an anti-tau antibody that is in a phase 1 trial in another disease ... Tau is a protein that ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...